Additionally, people with underlying health conditions such as liver disease, kidney disease, or immune-related disorders should undergo a thorough medical evaluation before considering treatment
7 Initiating and monitoring If adding a DPP-4 inhibitor to sulfonylurea, meglitinide or insulin therapy, consider whether a dose reduction of the sulfonylurea/meglitinide/insulin is needed to reduce hypoglycaemia risk
Kelly et al., 2015)
As of April 2026, estimates suggest that nearly half of online pharmacies still offering compounded GLP-1 products may be doing so in violation of FDA regulations, a gap that reflects enforcement capacity rather than regulatory ambiguity
For many patients, gastrointestinal side effects, including sulfur burps, diminish significantly after 8-12 weeks as physiologic adaptation occurs
Create a dedicated injection station Designate a specific spot in your home for injections